Horizon Therapeutics Plc (NASDAQ:HZNP)

About the company

Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

1200

$1B

Total Revenue

1K

Employees

$12B

Market Capitalization

18.97

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$1004M

Operating Margin (in %)

Total operating margin

$122M

Net Margin (in %)

Total net margin

$593M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12030.90 1376.00 5.13 18.97 43.06
Catalent, Inc. CTLT 10896.37 2872.00 5.47 104.47 3.63
Perrigo Co. Plc PRGO 7525.41 4837.00 1.29 51.34 3.02
Bausch Health Cos., Inc. BHC 6505.79 8597.00 9.08 -3.44 -21.96
Jazz Pharmaceuticals Plc JAZZ 6129.78 2188.00 2.12 22.40 12.81
United Therapeutics Corp. UTHR 5099.80 1443.00 1.77 9.84 36.59
MyoKardia, Inc. MYOK 4325.84 34.00 12.57 -13.95 -201.73
Axsome Therapeutics, Inc. AXSM 2963.17 None 20.11 -32.94 None
Pacira Biosciences, Inc. PCRX 2275.14 435.00 6.10 -5417.00 -0.02
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2181.92 9.00 2.56 -3.37 -413.06
Corcept Therapeutics, Inc. CORT 2023.98 335.00 4.65 19.07 31.64
Prestige Consumer Healthcare, Inc. PBH 1862.52 963.00 1.57 13.14 14.77
Madrigal Pharmaceuticals, Inc. MDGL 1617.30 0.00 4.32 -15.83 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1595.90 440.00 -22.59 18.82 19.14
Revolution Medicines, Inc. RVMD 1567.34 48.00 4.07 -22.14 -146.29
Innoviva, Inc. INVA 1534.54 285.00 3.63 7.94 66.41
Intercept Pharmaceuticals, Inc. ICPT 1397.92 272.00 -41.60 -4.08 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Zogenix, Inc. ZGNX 1246.21 5.00 3.40 -2.93 -241.62
Revance Therapeutics, Inc. RVNC 1230.46 0.00 4.86 -6.59 41.82
Theravance Biopharma, Inc. TBPH 1136.58 88.00 -7.98 -4.61 -280.80
Amphastar Pharmaceuticals, Inc. AMPH 1056.44 327.00 2.64 20.73 15.90
Endo International Plc ENDP 825.36 3014.00 -1.13 -2.94 -9.09
BellRing Brands, Inc. BRBR 771.22 954.00 -0.42 5.85 13.98
Assembly Biosciences, Inc. ASMB 693.39 16.00 3.11 -6.97 -601.75
Eagle Pharmaceuticals, Inc. EGRX 671.16 192.00 3.61 266.33 1.29
Aerie Pharmaceuticals, Inc. AERI 641.70 79.00 5.09 -3.17 -252.92
Collegium Pharmaceutical, Inc. COLL 593.64 299.00 4.25 -45.95 -4.21
Catalyst Pharmaceuticals, Inc. CPRX 537.14 119.00 5.23 12.24 36.09
Anika Therapeutics, Inc. ANIK 494.20 125.00 1.71 17.83 22.73
Intersect ENT, Inc. XENT 445.76 102.00 4.21 -8.93 -48.61
BioDelivery Sciences International, Inc. BDSI 401.12 130.00 5.74 -54.50 -5.01
ANI Pharmaceuticals, Inc. ANIP 367.56 203.00 1.88 -235.62 -0.67
Albireo Pharma, Inc. ALBO 332.41 11.00 3.38 -4.35 -730.55
MEI Pharma, Inc. MEIP 284.69 5.00 4.90 -7.30 -539.48
Mallinckrodt Plc MNK 199.08 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 163.43 None 2.66 -7.91 None
Marinus Pharmaceuticals, Inc. MRNS 161.60 0.00 6.26 -2.40 None
Cerecor, Inc. CERC 120.75 7.00 7.72 -5.36 -429.22
Ampio Pharmaceuticals, Inc. AMPE 95.81 1.00 67.00 -5.15 None
CTI BioPharma Corp. CTIC 91.45 3.00 4.08 -2.21 -111.83
Evoke Pharma, Inc. EVOK 89.28 None 31.00 -13.29 None
AcelRx Pharmaceuticals, Inc. ACRX 87.20 2.00 -1.60 -1.56 -644.25
Zynerba Pharmaceuticals, Inc. ZYNE 74.75 0.00 1.23 -2.08 -699.94
Adamas Pharmaceuticals, Inc. ADMS 71.96 57.00 -4.59 -0.78 -160.44
Aclaris Therapeutics, Inc. ACRS 68.88 4.00 1.21 -0.50 None
Oramed Pharmaceuticals, Inc. ORMP 60.48 3.00 4.87 -4.73 -464.15
Cassava Sciences, Inc. SAVA 59.28 41.00 3.12 -13.00 76.71
Cumberland Pharmaceuticals, Inc. CPIX 49.65 47.00 1.01 -11.03 -9.59
SCYNEXIS, Inc. SCYX 47.94 0.00 10.07 -1.24 -30.84
Natural Alternatives International, Inc. NAII 47.11 114.00 0.65 -12.46 -3.19
IsoRay, Inc. ISR 42.88 9.00 8.00 -12.80 -36.08
Lipocine, Inc. LPCN 39.60 0.00 9.43 -2.64 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.50 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 27.00 0.00 -2.59 -2.86 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.24 3.00 2.39 -1.62 -264.21
Regulus Therapeutics, Inc. RGLS 18.15 0.00 1.60 -0.85 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.65 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.66 None 1.37 -0.25 None
VIVUS, Inc. VVUS 8.88 73.00 -0.20 -0.30 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 6.37 19.00 1.01 -2.04 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Hepion Pharmaceuticals, Inc. HEPA 5.76 None 1.80 -0.48 None
Tonix Pharmaceuticals Holding Corp. TNXP 4.27 None 1.07 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Were Hedge Funds Right About Horizon Therapeutics Public Limited Company (HZNP)

1d ago, source: YAHOO!

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use ...

Horizon Therapeutics PLC (NASDAQ:HZNP) EVP Barry Moze Sells 23,158 Shares

4d ago, source: theenterpriseleader.com

EVP Barry Moze sold 23,158 shares of the company’s stock in a transaction dated Wednesday, July 1st. The shares were sold at ...

Fred Alger Management LLC Purchases 7,000 Shares of Horizon Therapeutics PLC (NASDAQ:HZNP)

10d ago, source: theenterpriseleader.com

Fred Alger Management LLC raised its position in shares of Horizon Therapeutics PLC (NASDAQ:HZNP) by 233.3% in the first ...

Horizon Therapeutics PLC

3d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

FY2021 Earnings Estimate for Horizon Therapeutics PLC (NASDAQ:HZNP) Issued By Jefferies Financial Group

13d ago, source: modernreaders.com

Equities research analysts at Jefferies Financial Group boosted their FY2021 earnings per share (EPS) estimates for Horizon ...

Is Horizon Therapeutics (HZNP) Stock a Solid Choice Right Now?

26d ago, source: YAHOO!

One stock that might be an intriguing choice for investors right now is Horizon Therapeutics plc HZNP. This is because this security in the Medical - Biomedical and Genetics space is seeing solid ...

Horizon Therapeutics (NASDAQ:HZNP) Trading Up 1%

13d ago, source: modernreaders.com

Horizon Therapeutics PLC (NASDAQ:HZNP)’s stock price was up 1% on Tuesday . The stock traded as high as $53.00 and last traded at $53.06, approximately 1,529,318 shares were traded during trading. A ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.